Europos Sąjunga - ispanų - EMA (European Medicines Agency)

janssen-cilag international n.v.    - clorhidrato de rilpivirina - infecciones por vih - antivirales para uso sistémico - edurant, en combinación con otros medicamentos antirretrovirales, está indicado para el tratamiento del virus de inmunodeficiencia humana tipo 1 (hiv‑1) infección en antirretrovirales treatment‑naïve pacientes de 12 años de edad y mayores con un carga viral ≤ 100.000 hiv‑1 copias de rna/ml. como con otros medicamentos antirretrovirales, de resistencia genotípica pruebas deben guiar el uso de edurant.

Europos Sąjunga - vokiečių - EMA (European Medicines Agency)

janssen-cilag international n.v.    - rilpivirinhydrochlorid - hiv-infektionen - antivirale mittel zur systemischen anwendung - edurant, wird in kombination mit anderen antiretroviralen arzneimitteln für die behandlung des humanen immundefizienz-virus typ 1 (hiv‑1) infektion bei antiretroviralen treatment‑naïve patienten 12 jahre und älter mit einer viruslast ≤ 100.000 hiv‑1 rna kopien/ml. wie bei anderen antiretroviralen arzneimitteln, genotypischen resistenzprüfung sollte die richtschnur für den einsatz von edurant.

Vokietija - vokiečių - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

bayer ag - wasserlösliches konzentrat - 360 g/l glyphosat ((als isopropylamin-salz 485 g/l)) - herbizid

Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

vsm geneesmiddelen b.v. - cundurango; - toedieningsweg:oraal gebruik - datum verstrekking handelsvergunning:22 januari 1999

Nyderlandai - olandų - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

vsm geneesmiddelen b.v. - cundurango d3; d6, d12, d30; 6k, 12k, 30k, 200k, mk, 10mk, 50mk, cmk; - datum verstrekking handelsvergunning:22 januari 1999

Izraelis - anglų - Ministry of Health

j-c health care ltd - rilpivirine as hydrochloride - tablets - rilpivirine as hydrochloride 25 mg - rilpivirine - rilpivirine - edurant™, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-naïve adult patients with hiv-1 rna less than or equal to 100,000 copies/ml at the start of therapy.

Europos Sąjunga - anglų - EMA (European Medicines Agency)

janssen-cilag international n.v.    - rilpivirine hydrochloride - hiv infections - antivirals for systemic use - edurant, in combination with other antiretroviral medicinal products, is indicated for the treatment of human immunodeficiency virus type 1 (hiv‑1) infection in antiretroviral treatment‑naïve patients 12 years of age and older with a viral load ≤ 100,000 hiv‑1 rna copies/ml. as with other antiretroviral medicinal products, genotypic resistance testing should guide the use of edurant.,

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

janssen products, lp - rilpivirine hydrochloride (unii: 212wax8kdd) (rilpivirine - unii:fi96a8x663) - rilpivirine 25 mg - edurant, in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-naïve patients 12 years of age and older and weighing at least 35 kg with plasma hiv-1 rna less than or equal to 100,000 copies/ml at the start of therapy. limitations of use: - more edurant treated subjects with hiv-1 rna greater than 100,000 copies/ml at the start of therapy experienced virologic failure (hiv-1 rna ≥50 copies/ml) compared to edurant treated subjects with hiv-1 rna less than or equal to 100,000 copies/ml [see clinical studies (14.1)] . edurant is indicated in combination with vocabria (cabotegravir) for short-term treatment of hiv-1 infection in adults and adolescents 12 years and older and weighing at least 35 kg who are virologically suppressed (hiv-1 rna less than 50 copies/ml) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir

Bangladešas - anglų - DGDA (Directorate General of Drug Administration)

deeplaid pharmaco ltd. (homoeo) - condurango - liquid

Bangladešas - anglų - DGDA (Directorate General of Drug Administration)

dhaka homoeo hall (pvt) ltd. - condurango - liquid